Combination of tyrosine kinase inhibitor and her-2/neu for...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/00 (2006.01) A61K 31/517 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2589981

A method of treating cancer is described comprising administration of a 4~quinazolineamine and a vaccine targeting the HER-2/neu molecule, as well as a pharmaceutical combination comprising 4-quinazolineamines and a vaccine targeting the HER-2/neu molecule.

L'invention concerne un procédé de traitement du cancer qui consiste à administrer une 4-quinazolineamine et un vaccin ciblant la molécule HER-2/neu, et une combinaison pharmaceutique qui renferme des 4-quinazolineamines et un vaccin ciblant la molécule HER-2/neu.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combination of tyrosine kinase inhibitor and her-2/neu for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination of tyrosine kinase inhibitor and her-2/neu for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination of tyrosine kinase inhibitor and her-2/neu for... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1684970

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.